Evaluating zuranolone: Discrepancies and insights from multiple systematic reviews and meta-analyses on major depression and postpartum depression treatment
Zuranolone, a novel neuroactive steroid and positive allosteric modulator of γ-aminobutyric acid type A (GABAA) receptors, has been explored for its potential in treating major depressive disorder (MDD) and postpartum depression (PPD). This review compiles findings from multiple systematic reviews a...
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Elsevier
2025-12-01
|
| Серии: | Brain Disorders |
| Предметы: | |
| Online-ссылка: | http://www.sciencedirect.com/science/article/pii/S266645932500112X |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|